Jefferies Downgrades BioForm Medical (BFRM) to Hold
BFRM Hot Sheet
Rating Summary:0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Jefferies downgrades BioForm Medical (Nasdaq: BFRM) from Buy to Hold. Price target $5.50.
To see all the upgrades/downgrades on shares of BFRM, visit our Analyst Ratings page.
BioForm Medical, Inc. (BioForm) is a medical aesthetics company focused on developing and commercializing products that are used by physicians to enhance a patient’s appearance.
To see all the upgrades/downgrades on shares of BFRM, visit our Analyst Ratings page.
BioForm Medical, Inc. (BioForm) is a medical aesthetics company focused on developing and commercializing products that are used by physicians to enhance a patient’s appearance.
You May Also Be Interested In
- UPDATE: UBS Downgrades Wisconsin Energy (WEC) to Neutral; Taking Some Off The Table
- Needham & Company Reiterates a 'Buy' on UQM Technologies (UQM); Increasing EV Adoption
- UBS Maintains a 'Buy' on Teva Pharma (TEVA); CEO Highlights From Conference Call
Create E-mail Alert Related Categories
DowngradesRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
